UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

FDA recall notice · announced January 1, 2025 · Mxbbb

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

Reason for recall

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Notes

Distribution: Product was sold via Amazon Marketplace.
Lot/code information: Lot#: 24183, Exp 07/01/28
Quantity: 321 bottles
Status: Ongoing
Products in this recall event:
- UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323 (D-0166-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.